| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 02/01/2025 | 13:30 | GlobeNewswire Inc. | TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses | NASDAQ:SIGA | SIGA Technologies Inc |
| 13/12/2024 | 22:46 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SIGA | SIGA Technologies Inc |
| 10/12/2024 | 22:00 | GlobeNewswire Inc. | Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced | NASDAQ:SIGA | SIGA Technologies Inc |
| 08/11/2024 | 23:31 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:SIGA | SIGA Technologies Inc |
| 07/11/2024 | 22:55 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SIGA | SIGA Technologies Inc |
| 07/11/2024 | 22:05 | GlobeNewswire Inc. | SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024 | NASDAQ:SIGA | SIGA Technologies Inc |
| 31/10/2024 | 12:30 | GlobeNewswire Inc. | SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results | NASDAQ:SIGA | SIGA Technologies Inc |
| 29/10/2024 | 22:03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SIGA | SIGA Technologies Inc |
| 22/10/2024 | 13:30 | GlobeNewswire Inc. | SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies | NASDAQ:SIGA | SIGA Technologies Inc |
| 08/10/2024 | 13:30 | GlobeNewswire Inc. | SIGA Announces Agreement to Supply TPOXX® in Morocco | NASDAQ:SIGA | SIGA Technologies Inc |
| 21/08/2024 | 22:00 | GlobeNewswire Inc. | SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® | NASDAQ:SIGA | SIGA Technologies Inc |
| 15/08/2024 | 13:35 | GlobeNewswire Inc. | Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released | NASDAQ:SIGA | SIGA Technologies Inc |
| 01/08/2024 | 22:05 | GlobeNewswire Inc. | SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024 | NASDAQ:SIGA | SIGA Technologies Inc |
| 25/07/2024 | 13:30 | GlobeNewswire Inc. | SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results | NASDAQ:SIGA | SIGA Technologies Inc |
| 19/07/2024 | 14:00 | GlobeNewswire Inc. | SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX® | NASDAQ:SIGA | SIGA Technologies Inc |
| 17/06/2024 | 22:05 | GlobeNewswire Inc. | SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States | NASDAQ:SIGA | SIGA Technologies Inc |
| 07/05/2024 | 22:05 | GlobeNewswire Inc. | SIGA Reports Financial Results for Three Months Ended March 31, 2024 | NASDAQ:SIGA | SIGA Technologies Inc |
| 01/05/2024 | 23:00 | GlobeNewswire Inc. | SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results | NASDAQ:SIGA | SIGA Technologies Inc |
| 01/04/2024 | 22:05 | GlobeNewswire Inc. | SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX® | NASDAQ:SIGA | SIGA Technologies Inc |
| 25/03/2024 | 12:30 | GlobeNewswire Inc. | SIGA Names Larry Miller General Counsel | NASDAQ:SIGA | SIGA Technologies Inc |
| 12/03/2024 | 21:05 | GlobeNewswire Inc. | SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023 | NASDAQ:SIGA | SIGA Technologies Inc |
| 12/03/2024 | 12:30 | GlobeNewswire Inc. | SIGA Declares Special Cash Dividend of $0.60 Per Share | NASDAQ:SIGA | SIGA Technologies Inc |
| 05/03/2024 | 13:30 | GlobeNewswire Inc. | SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:SIGA | SIGA Technologies Inc |
| 01/02/2024 | 21:54 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:SIGA | SIGA Technologies Inc |
| 30/01/2024 | 23:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:SIGA | SIGA Technologies Inc |
| 22/01/2024 | 13:30 | GlobeNewswire Inc. | SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer | NASDAQ:SIGA | SIGA Technologies Inc |
| 07/11/2023 | 22:05 | GlobeNewswire Inc. | SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023 | NASDAQ:SIGA | SIGA Technologies Inc |
| 26/10/2023 | 13:30 | GlobeNewswire Inc. | SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results | NASDAQ:SIGA | SIGA Technologies Inc |
| 23/10/2023 | 14:00 | GlobeNewswire Inc. | SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries | NASDAQ:SIGA | SIGA Technologies Inc |
| 06/09/2023 | 13:30 | GlobeNewswire Inc. | SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer | NASDAQ:SIGA | SIGA Technologies Inc |